Archive: 9/07/2012

New test helps evaluate cancer drug's merit

(HealthDay) -- A new genetic test to help doctors determine if the drug Erbitux would be an effective treatment for certain colorectal cancer patients has been approved by the U.S. Food and Drug Administration.

page 1 from 8